Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Patent
1997-02-21
1999-09-07
Moezie, Minna
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
4241951, 424638, 424648, 424655, 424656, 424687, 424692, 514 52, 514161, 514162, 514163, 514164, 514165, 514167, 514168, 514249, 514251, 514276, 514345, 514356, 514387, 514440, 514456, 514458, 514474, 514494, 514499, 514500, 514502, 514505, 514556, 514557, 514561, 514563, 514578, 514678, 514725, 514729, 514762, 514904, 514905, A61K 3332, A61K 3162
Patent
active
059484438
ABSTRACT:
The present invention pertains generally to the field of Public Health, including the prevention and treatment of coronary heart disease which is currently the first cause of death in the American population. More specifically, the present invention concerns a total modular system of multivitamin and mineral supplementation composed of 7 distinct modules for improving public health by insuring adequate intake of micronutrients needed for disease prevention and protection against nutritional losses and deficiencies due to, for example, lifestyle factors and common inadequate dietary patterns. A module, as used herein throughout, is defined as a separate and distinct combination of vitamin-mineral and other health promoting compounds which are directed to specific target populations. The formulations of the present invention which, when combined in one capsule or tablet or as separate modules, exert a joint and enhancing effect on the major pathogenetic factors involved in the atherosclerotic process. Moreover, certain modular formulations of the present invention incorporate both antioxidants and acetylsalicylic acid (aspirin) as a single preventive modality. Such a combination of antioxidants and aspirin is believed to act to prevent oxidation of low density lipoproteins within coronary arterial walls and to cause platelet deagluttination thereby inhibiting thrombus formation. The benefit of preventing these two major processes is believed to reduce the risk of coronary heart disease.
REFERENCES:
patent: 4158705 (1979-06-01), Malley
patent: 4826679 (1989-05-01), Roy
patent: 4976960 (1990-12-01), Grossman et al.
patent: 5118505 (1992-06-01), Koltringer
patent: 5256538 (1993-10-01), Aiken et al.
patent: 5356636 (1994-10-01), Schneider et al.
patent: 5514382 (1996-05-01), Sultenfuss
patent: 5571441 (1996-11-01), Andon et al.
patent: 5626849 (1997-05-01), Hastings et al.
patent: 5648377 (1997-07-01), Bombardelli et al.
patent: 5654011 (1997-08-01), Jackson et al.
U.S. Department of Health and Human Services, Healthy People 2,000: National Health Promotion and Disease Prevention Objectives, Dept. of Human Services, Conference Edition, Sep. 1990--Part I; Part II: Introduction, Ch. 2 Nutrition, Ch. 5 Heart Disease and Stroke.
Jialal, A. et al., J. Nutr. 126: 1053S-1057S, 1996.
Maggi, E., M.D., et al., Coronary Artery Disease 4(12): 1119-1122, 1993.
Hirose, N. et al., Keio J Med 45 (2): 90-94, 1996.
Levy, Y. et al., Isr J Med Sci 32: 473-478, 1996.
Preobrazhensky, S. et al., Analytical Biochemistry 227(1): 225-234, 1995.
Mackness, M. et al., Biochem J.: 294: 829-834, 1993 (Printed in Great Britain).
Porkkala-Sarataho, E., et al., Atherosclerosis 124(1): 83-94, 1996.
Jialal, I., M.D. et al., Circulation 88: 2780-2786, 1993.
Frei, B., Critical Reviews in Food Science and Nutrition 35(1&2) 83-98, 1995.
Halliwell, B., Am J Clin Nutr; 61 (3) 670S-7S, 1995.
Helzlsouer, K. et al., Cancer Research, 54 (7 Suppl): 2044S-2051S, 1994.
Stahelin, H.B. Supportive Care in Cancer 1(6): 295-7, 1993.
Bartosiewicz, G. et al, Therapia Hungarica 41(2):67-71, 1993 (English Abstract Only).
Hallfrisch, J. et al., Am J Clin Nutr 60(2): 176-82, 1994.
Statistical Bulletin of Metropolitan Ins. Co., 73(3): 2-9, Jul.-Sep. 1992.
Schroll, M., Danish Med Bull 39(3): 258-61, 1992.
Sohal, R. et al., Mechanisms Of Aging and Development 53(3): 217-227, 1990.
Nutritional Checklist , Nutrition Screening Initiative, Washington, D.C., 20037, pp. 1-3, 1994.
Fairbanks, V., in Modern Nutrition in Health and Disease, 8th Edition, vol. I, Ch. 9, 1994.
Reynolds, J., et al Calc. Tiss. Res. 12, 295-301, 1973.
Chandra, R., M.D., JAMA 1984; 252:1443-46.
King, J. et al., in Mod Nutr in Health and Disease, 8th Edition, vol. I, Ch. 10, 1994.
Meydani, S., Nutrition Reviews, 51(4): 106-115, 1993.
Chandra, R., Lancet 340: 1124-27, 1992.
Meydani, S. et al., Am J Clin Nutr; 53(5): 1275-80, 1991.
Malkowska-Zwierz, W. et al., Archivum Immunologiae et Therapiae Experimentalis 39(1-2): 109-15, 1991 (English Abstract Only).
Meydani, S., Am J Clin Nutr 53(4): 984, 1991.
Dhur, A. et al., Comp. Biochem. Physiol, 96C(2): 271-280, 1990.
Blomhoff, H. et al., The Journal of Biological Chemistry, 267(33):23988-23992, 1992.
Garbe, A. et al., J. Exp Med., 176(7): 109-117, 1992.
Buck, J. et al., J. Exp. Med. 171: 1613-1624, 1990.
Prabhala, R. et al., Cancer 67(6):1556-1560, 1991.
Porsova-Dutoit, I. et al., Endocrine Regulations, 27: 75-82, 1993.
Kreutz, M. et al., Blood, 76(12): 2457-2461, 1990.
Jacob, R. et al., Am J Clin Nutr, 54(6): 1302S-9S, 1991.
Kramer, T. et al., Am J Clin Nutr, 58(4): 566-70, 1993.
Trujillo. E., Journal of Vascular Nursing, 11(1): 12-18, 1993.
Goode, H. et al., BMJ 305: 925-7, 1992.
Maderazo, E. et al., The Journal of Trauma, 31(8): 1142-50, 1991.
Brolin, R. et al., International Journal of Obesity, 15(10), 661-667, 1991.
Ngyen, T. et al., J Burn Care Rehabil; 14(6): 602-9, 1993.
National Institutes of Health, 5(3): 421-132, 1984.
NIH, NIH Consenssus Statement, 12(4): 1-31, 1994.
Offenbacher et al., Diabetes, 29: 919-925, 1980.
Steering Committee of the Physicians Health Study Research Group, The New England Journal of Medicine, 321(3): 129-135, 1989.
Kendrick, Z.V. et al., in Exercise, Nutrition, and Energy Metabolism, Chapter 14, 1988.
Violi, F. et al., Atherosclerosis, 82: 247-252, 1990.
Hockertz, S. et al., Arzneim-Forsch. 42: 1062-8, 1992.
Zhen, G. et al., Acta Pharmacologica Sinica, 14(3): 263-265, 1993 (English Abstract Only).
McAlindon, M. et al., Gut 38(4): 518-24, 1996.
Hennekens, C., Am Heart J 128: 1333-6, 1994.
Vasconcellos C. et al., Blood 82(12): 3648-3657, 1993.
Lee S. et al., Vet Human Toxicol 37(3): 224-5, 1995.
Lotzerich, H. et al., Anticancer Research 13(1), 87-92, 1993.
Brouard, C. et al., Ann Nutr Metab 37(3): 146-159, 1993.
Claria, J. et al., Proc. Natl. Acad. Sci. USA, 92(21): 9475-9479, 1995.
Ames, B. et al., Pro. Natl. Acad. Sci. USA, 90: 7915-7922, 1993.
Manson, J. et al., Ann Epidemiol, 5: 261-269, 1995.
Christakis, G., in Nutrient Additions to Food, Chapter 18, 1990.
Steiner M. et al., Biosis Abstract 96: 65876, Doc. #98638011, 1995.
Schatzkin, A. et al., Biosis Abstract 95: 456683, Doc. #98470983, 1995.
Biosis abstract 96: 65876, Document No. 98638011, (1995) Steiner, M. et al.
Biosis abstract 95: 456683, Document No. 98470983, (1995) Schatzkin, A. et al.
Christakis George
Riley Patricia A.
Medical Doctor's Research Institute, Inc.
Moezie Minna
LandOfFree
Acetylsalicylic acid and micronutrient supplementation for nutri does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acetylsalicylic acid and micronutrient supplementation for nutri, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acetylsalicylic acid and micronutrient supplementation for nutri will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1802392